The new research focused specifically on associations between background parenchymal enhancement—a known risk factor for breast cancer, visualized on surveillance MRI exams—and secondary breast cancers.

A governmental healthcare provider in Canada has begun reviewing mammography results from around 3,000 patients imaged over the past three years.

MRI-directed contrast enhanced mammography could serve as a useful stand-alone or complimentary tool for biopsy planning when suspicious lesions are detected. 

Nearly 20% of the women included in the study did not complete their follow-up imaging at all, and out of the 3,648 women who did adhere to additional imaging, 23.3% delayed their exams beyond the recommended 60-day period.

Experts arrived at this conclusion after comparing incidents of hematoma between patients who did and did not receive antithrombotic therapy prior to their procedure.

The authors of the new study noted that, even before the pandemic, consultant breast radiologists were among the most in-demand specialists. The loss of interest in it as a specialty due to COVID will inevitably pose further challenges for recruitment.

Many women who receive their mammogram results on the same day as their exam report feeling better about their overall experience. 

Keith J. Dreyer, DO, PhD, FACR, American College of Radiology (ACR) Data Science Institute Chief Science Officer, explains how radiology vendors have developed AI app stores to make it easier to access new FDA cleared AI algorithms.